Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. ( (AU:IBX) ) has shared an update.
Imagion Biosystems has entered a collaboration with Wayne State University to enhance its molecular imaging capabilities using its MagSense® technology. This partnership, alongside Siemens Healthineers, aims to develop advanced MRI protocols and quantitative imaging techniques that enable AI-based cancer diagnostics. The collaboration is expected to improve diagnostic accuracy, democratize access to advanced imaging, and accelerate the development of AI diagnostics, potentially transforming cancer detection and patient care.
More about Imagion Biosystems Ltd.
Imagion Biosystems Ltd. operates in the healthcare industry, focusing on the early detection of cancer through its proprietary MagSense® imaging technology. The company collaborates with leading organizations to enhance molecular imaging capabilities, aiming to improve diagnostic accuracy and patient outcomes.
Average Trading Volume: 4,658,224
Technical Sentiment Signal: Sell
Current Market Cap: A$3.94M
See more insights into IBX stock on TipRanks’ Stock Analysis page.